1. Home
  2. JFIN vs PRME Comparison

JFIN vs PRME Comparison

Compare JFIN & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JFIN
  • PRME
  • Stock Information
  • Founded
  • JFIN 2011
  • PRME 2019
  • Country
  • JFIN China
  • PRME United States
  • Employees
  • JFIN N/A
  • PRME N/A
  • Industry
  • JFIN Finance: Consumer Services
  • PRME Medicinal Chemicals and Botanical Products
  • Sector
  • JFIN Finance
  • PRME Health Care
  • Exchange
  • JFIN Nasdaq
  • PRME Nasdaq
  • Market Cap
  • JFIN 682.1M
  • PRME 693.5M
  • IPO Year
  • JFIN 2019
  • PRME 2022
  • Fundamental
  • Price
  • JFIN $11.15
  • PRME $5.95
  • Analyst Decision
  • JFIN
  • PRME Buy
  • Analyst Count
  • JFIN 0
  • PRME 6
  • Target Price
  • JFIN N/A
  • PRME $8.88
  • AVG Volume (30 Days)
  • JFIN 90.9K
  • PRME 3.9M
  • Earning Date
  • JFIN 11-19-2025
  • PRME 11-11-2025
  • Dividend Yield
  • JFIN 7.06%
  • PRME N/A
  • EPS Growth
  • JFIN 33.85
  • PRME N/A
  • EPS
  • JFIN 4.21
  • PRME N/A
  • Revenue
  • JFIN $908,895,698.00
  • PRME $4,961,000.00
  • Revenue This Year
  • JFIN N/A
  • PRME $179.58
  • Revenue Next Year
  • JFIN N/A
  • PRME N/A
  • P/E Ratio
  • JFIN $2.68
  • PRME N/A
  • Revenue Growth
  • JFIN 8.19
  • PRME 739.42
  • 52 Week Low
  • JFIN $5.18
  • PRME $1.11
  • 52 Week High
  • JFIN $19.23
  • PRME $6.94
  • Technical
  • Relative Strength Index (RSI)
  • JFIN 44.45
  • PRME 63.82
  • Support Level
  • JFIN $10.18
  • PRME $4.87
  • Resistance Level
  • JFIN $11.64
  • PRME $6.94
  • Average True Range (ATR)
  • JFIN 0.46
  • PRME 0.49
  • MACD
  • JFIN 0.17
  • PRME 0.08
  • Stochastic Oscillator
  • JFIN 73.97
  • PRME 55.90

About JFIN Jiayin Group Inc.

Jiayin Group Inc is China's technology service group. It is an enterprise engaged in technological innovation services. It is committed to using big data, cloud computing, artificial intelligence and other technologies to connect consumers and financial institutions in consumption scenarios so that every user can enjoy efficient and convenient technology services. The company has engraved technological innovation into the company's development genes since its establishment, adheres to the dual drive of digital plus technology, and focuses on building a cloud service platform and intelligent risk control system with big data drive as the core concept.

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Share on Social Networks: